UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2021 | 2022-02-17 | 0.00 | 0.00 |
| Q3 2021 | 2021-11-08 | -0.18 | -0.18 |
| Q2 2021 | 2021-08-05 | -0.23 | -0.23 |
| Q1 2021 | 2021-05-06 | -0.25 | -0.25 |
| Q4 2020 | 2021-02-10 | -0.24 | -0.24 |
| Q3 2020 | 2020-11-05 | -0.08 | -0.08 |
| Q2 2020 | 2020-08-06 | -0.18 | -0.18 |
| Q1 2020 | 2020-05-07 | -0.23 | -0.23 |
| Q4 2019 | 2020-02-10 | -0.18 | -0.18 |
| Q3 2019 | 2019-11-05 | -0.19 | -0.19 |
| 2016-06-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2016-06-01 | Initiated Coverage | Deutsche Bank | Buy | |
| 2016-06-01 | Initiated Coverage | Deutsche Bank AG | Buy | |
| 2016-05-06 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2016-05-05 | Lower Price Target | Mizuho | Buy | $11.00 to $8.00 |
| 2016-04-12 | Lower Price Target | Leerink Swann | Outperform | $20.00 to $15.00 |
| 2016-04-01 | Reiterated Rating | Leerink Swann | Outperform | $20.00 |
| 2016-02-08 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2016-02-08 | Reiterated Rating | Deutsche Bank | Buy | |
| 2016-02-05 | Lower Price Target | Deutsche Bank | $18.00 to $17.00 | |
| 2016-02-05 | Upgrade | Mizuho | Neutral to Buy | $8.00 |
| 2016-01-20 | Reiterated Rating | Cowen and Company | Outperform to Market Perform | |
| 2016-01-16 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-01-06 | Initiated Coverage | Deutsche Bank | Buy | $18.00 |
| 2016-01-06 | Initiated Coverage | Avondale Partners | Outperform | $20.00 |
| 2015-10-30 | Upgrade | Cantor Fitzgerald | Hold to Buy | $15.00 to $12.00 |
| 2015-10-30 | Boost Price Target | Mizuho | Neutral | $8.00 to $15.00 |
| 2015-10-26 | Lower Price Target | Leerink Swann | Outperform | $28.00 to $20.00 |
| 2015-10-02 | Reiterated Rating | Cowen and Company | Outperform | $15.00 to $13.00 |
| 2015-09-10 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-08-27 | Reiterated Rating | Maxim Group | Hold | $15.00 |
| 2015-08-26 | Initiated Coverage | Cantor Fitzgerald | Hold | $15.00 |
| 2015-08-09 | Reiterated Rating | Mizuho | Hold | |
| 2015-08-07 | Lower Price Target | Cowen and Company | Outperform | $32.00 to $15.00 |
| 2015-08-07 | Reiterated Rating | Leerink Swann | Buy | $45.00 to $28.00 |
| 2015-08-07 | Downgrade | Piper Jaffray | Overweight to Neutral | $43.00 to $15.00 |
| 2015-08-07 | Lower Price Target | Mizuho | Neutral | $30.00 to $15.00 |
| 2015-08-07 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $43.00 to $15.00 |
| 2015-07-01 | Lower Price Target | Cowen and Company | Outperform | $45.00 to $32.00 |
| 2015-06-10 | Set Price Target | Piper Jaffray | Buy | $43.00 |
| 2015-05-19 | Reiterated Rating | Leerink Swann | Outperform | $45.00 |
| 2015-05-11 | Reiterated Rating | Cantor Fitzgerald | Buy | $42.00 |
| 2015-05-08 | Lower Price Target | Maxim Group | Buy | $52.00 to $44.00 |
| 2015-05-08 | Downgrade | Mizuho | Buy to Neutral | $50.00 to $30.00 |
| 2015-03-05 | Boost Price Target | Leerink Swann | Outperform | $47.00 to $52.00 |
| 2015-03-02 | Set Price Target | Cantor Fitzgerald | Buy | $48.00 |
| 2015-02-09 | Reiterated Rating | Cantor Fitzgerald | Buy | $45.00 |
| 2015-01-20 | Upgrade | Cowen and Company | Market Perform to Outperform | $32.00 to $40.00 |
| 2014-05-06 | Lower Price Target | Maxim Group | Buy | $65.00 to $52.00 |
| 2014-05-06 | Reiterated Rating | Piper Jaffray | Overweight | $51.00 to $50.00 |
| 2014-05-06 | Lower Price Target | Leerink Swann | $52.00 to $48.00 | |
| 2014-04-23 | Upgrade | Mizuho | Neutral to Buy | $43 to $50 |
| 2014-04-22 | Upgrade | Mizuho | Neutral to Buy | $43.00 to $50.00 |
| 2014-04-14 | Upgrade | Leerink Swann | Market Perform to Outperform | $45.00 to $52.00 |
| 2014-03-21 | Boost Price Target | Maxim Group | Buy | $52.00 to $65.00 |
| 2014-02-07 | Downgrade | Cowen and Company | Outperform to Market Perform | $42.00 to $45.00 |
| 2014-02-03 | Boost Price Target | Oppenheimer | Outperform | $46.00 to $52.00 |
| 2014-01-14 | Boost Price Target | Mizuho | Neutral | $30.00 to $43.00 |
| 2013-12-18 | Boost Price Target | Maxim Group | Buy | $33.00 to $42.00 |
| 2013-12-05 | Reiterated Rating | Oppenheimer | Outperform | $28.00 to $35.00 |
| 2013-10-31 | Boost Price Target | Maxim Group | Buy | $26.00 to $33.00 |
| 2013-10-31 | Boost Price Target | Cowen and Company | Outperform | $26.00 to $29.00 |
| 2013-10-31 | Boost Price Target | Cantor Fitzgerald | Buy | $23.00 to $28.00 |
| 2013-10-31 | Boost Price Target | Mizuho | Neutral | $19.00 to $30.00 |
| 2013-08-02 | Reiterated | Mizuho | Neutral | $17 to $19 |
| 2013-08-02 | Reiterated | Maxim Group | Buy | $21 to $23 |
| 2012-02-15 | Reiterated | Deutsche Bank | Buy | $16 to $19.50 |
| 2016-06-02 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2016-06-01 | Initiated Coverage | Deutsche Bank | Buy | |
| 2016-06-01 | Initiated Coverage | Deutsche Bank AG | Buy | |
| 2016-05-06 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2016-05-05 | Lower Price Target | Mizuho | Buy | $11.00 to $8.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In FLDM 65 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Indaba Capital Management, LLC | 7.45M |
| PRIMECAP MANAGEMENT CO/CA/ | 4.93M |
| Neuberger Berman Group LLC | 4.36M |
| Vanguard Group, Inc | 3.95M |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 3.87M |
| MORGAN STANLEY | 2.89M |
| BlackRock Inc. | 1.99M |
| RUSSELL FRANK CO/ | 1.13M |
| Concept Capital Markets, LLC | 0.98M |
| BlackRock Fund Advisors | 0.89M |
| D. E. Shaw & Co., Inc. | 0.81M |
| BlackRock Institutional Trust Company, N.A. | 0.80M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.71M |
| TEACHERS ADVISORS INC | 0.48M |
| DIMENSIONAL FUND ADVISORS LP | 0.39M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. Passive Investor | 4.57% (1287450) | FLDM / |
| Linthwaite Stephen Christopher President & COO | 0.42% (119702) | FLDM / |
| COLELLA SAMUEL D | 0.26% (71923) | ALXA / FLDM / FLXN / GHDX / VCYT / |
| JONES EVAN/ FA | 0.21% (58551) | CASM / FLDM / FMI / VCYT / |
| McPhail Steven GM, PRODUCTION GENOMICS | 0.11% (31828) | FLDM / |
| BARTHELEMY NICOLAS | 0.09% (26362) | FLDM / RGEN / |
| Burbach Gerhard F | 0.09% (24115) | FLDM / THOR / |
| Yow Mai Chan See Remarks | 0.06% (17660) | FLDM / |
| Paya Carlos V | 0.06% (15734) | FLDM / IMDZ / |
| JOG VIKRAM CHIEF FINANCIAL OFFICER | 0.04% (11674) | FLDM / |
| Worthington Gajus Vincent PRESIDENT & CEO | 0.04% (11513) | FLDM / |
| Khadder Nicholas See Remarks | 0.03% (7435) | AMRS / FLDM / |
| LEE JENNIFER LING See Remarks | 0.02% (6716) | FLDM / |
| YOUNG JOHN A | 0.02% (5849) | FLDM / VRML / |
| UNGER MARC See Remarks | 0.02% (5377) | FLDM / |
| JONES PATRICK S | 0.02% (5000) | DLGC / FLDM / LSCC / UPIP / |
| JONES ROBERT C EVP, RESEARCH & DEVELOPMENT | 0.01% (3282) | FLDM / |
| Smith William Maxwell See Remarks | 0.01% (3257) | FLDM / |
| Walder Fredric T CHIEF OPERATING OFFICER | 0.01% (2915) | FLDM / |
UM